CEO

• D.Sc., the Technion, Israel

• >25 years experience in the plasma and biotechnology industries.

• CEO and Head of R&D, Omri Laboratories Ltd.

• CEO at Quiet Therapeutics Ltd.

• VP development at KAHR Medical Ltd.

• CEO at BM Biotech Ltd.

 moshe@eiobio.com

CMO

• Highly experienced surgeon (over 25 years)

• Sr. Surgeon Kaplan Medical Center in Rehovot, Israel

• Specialty in hepatobiliary, pancreatic, oncological surgery

       miller_r@eiobio.com

Chairman of the BOD, CEO of NGT3

• Former CEO and director of Beta-O2 Technologies

• Served as CEO of the Technion Entrepreneurial Incubator - 11 years.

• Led the establishment and investment in more than 50 companies including: Prolor Biotech (sold to OPKO, NYSE: OPK), Mazor Robotics (NASDAQ: MZOR), ReWalk (NASDAQ: RWLK), Corindus (NASDAQ: CVRS), Regentis and many others.

Founder & board member

• Ph.D. Weizmann Institute of Science, Israel
  Post-doctoral research fellow in the Salk Institute (San Diego, CA) and in the Max Planck Institute for Medical Research (Heidelberg, DE)
  Glenn foundation fellow, Minerva foundation fellow
  R&D group leader and technical project manager in Johnson & Johnson
  Key leadership positions in start-up companies
  yair@eiobio.com
   

Board member and financial advisor

• President of Wexford Capital Israel (formerly Pattern Model).

• 30 years’ experience in the financial market in senior positions.

• Lt. Col. (retired) IDF intelligence.

• Ph.D. in statistics, UC Berkley

• M.B.A., Columbia University

Director of Business Development

• Over 30 Years experience in Pharmaceutical Industry. 

• VP Business development at Perrigo IL

• VP Pharmaceutical supply Chain – Teva Europe

• Senior positions in Teva (Director Commercial Operations Central Teva East Europe; Director, Teva Corporate Business development (M&A))

QA manager

M.sc. From Tel Hai Academy College

Sr. Research associate at Migal-Galillee Research Institute